Concord Biotech Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Concord Biotech Limited has submitted a routine compliance certificate to NSE and BSE as required under SEBI regulations. The certificate, issued by MUFG Intime India Private Limited (the company's Registrar and Share Transfer Agent), confirms that no requests for dematerialization or rematerialization of equity shares were received during the quarter ending March 31, 2026. This filing dated April 8, 2026, covers the Q4 FY26 period. The company maintains its registered office in Dholka, Ahmedabad, Gujarat, and is listed on both NSE (CONCORDBIO) and BSE (Scrip Code: 543960).
This is a standard regulatory compliance filing with no material impact on shareholders or stock performance. It simply confirms routine share dematerialization activity status.